In recent trading session, Biofrontera Inc (NASDAQ:BFRI) saw 0.51 million shares changing hands at last check today with its beta currently measuring 0.41. Company’s recent per share price level of $0.64 trading at -$0.06 or -8.56% at last check today assigns it a market valuation of $6.04M. That most recent trading price of BFRI’s stock is at a discount of -246.88% from its 52-week high price of $2.22 and is indicating a discount of -1.56% from its 52-week low price of $0.65.
For Biofrontera Inc (BFRI), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Biofrontera Inc (NASDAQ:BFRI) trade information
Upright in the red during last session for losing -8.56%, in the last five days BFRI remained trading in the red while hitting it’s week-highest on Thursday, 05/15/25 when the stock touched $0.64 price level, adding 16.67% to its value on the day. Biofrontera Inc’s shares saw a change of -41.28% in year-to-date performance and have moved -7.90% in past 5-day. Biofrontera Inc (NASDAQ:BFRI) showed a performance of -23.35% in past 30-days.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 29.20% during past 5 years.
On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 32.22 shares of worth $20841.0 or 0.35% of the total outstanding shares. The later fund manager was in possession of 8.61 shares on Dec 31, 2024 , making its stake of worth around $5569.0 in the company or a holder of 0.09% of company’s stock.
